Browsing Tag
Chronic Spontaneous Urticaria
5 posts
Briquilimab shows promising asthma signal in ETESIAN study as Jasper Therapeutics resolves BEACON probe
Discover how Jasper Therapeutics reignited confidence in briquilimab with new asthma data and a clarified BEACON investigation.
InflaRx prepares for key INF904 Phase 2a topline readout in chronic skin inflammation trials
Find out how InflaRx’s INF904 topline Phase 2a data could redefine treatment for hidradenitis suppurativa and chronic spontaneous urticaria.
Jasper Therapeutics reports promising results for Briquilimab in Chronic Urticaria treatment
Jasper Therapeutics, Inc., a biotechnology company specializing in treatments for mast cell-driven diseases, has released groundbreaking preliminary results…
CuraTeQ Biologics achieves milestone in Omalizumab biosimilar development
CuraTeQ Biologics Private Limited, a fully integrated arm of Aurobindo Pharma Ltd, has announced significant progress in its…
Novartis’ remibrutinib shows promising results in Phase III studies for chronic spontaneous urticaria
Novartis has revealed encouraging data from the Phase III REMIX-1 and REMIX-2 studies. The studies focused on remibrutinib,…